These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22825670)

  • 1. Anticoagulants in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Ingram AJ; Herzog CA
    Nat Rev Nephrol; 2012 Oct; 8(10):569-78. PubMed ID: 22825670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation.
    Stamellou E; Floege J
    Nephrol Dial Transplant; 2018 Oct; 33(10):1683-1689. PubMed ID: 29206932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
    Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral anticoagulation in chronic kidney disease with atrial fibrillation].
    Expósito V; Seras M; Fernández-Fresnedo G
    Med Clin (Barc); 2015 May; 144(10):452-6. PubMed ID: 24889748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.
    Bhatia HS; Bailey J; Unlu O; Hoffman K; Kim RJ
    Pacing Clin Electrophysiol; 2019 Nov; 42(11):1463-1470. PubMed ID: 31599969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
    Feldberg J; Patel P; Farrell A; Sivarajahkumar S; Cameron K; Ma J; Battistella M
    Nephrol Dial Transplant; 2019 Feb; 34(2):265-277. PubMed ID: 29509922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
    Schneeweiss S; Gagne JJ; Patrick AR; Choudhry NK; Avorn J
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):480-6. PubMed ID: 22787066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease Stage G4: A Single-Center Experience.
    Heleniak Z; Papuga-Szela E; Krzysztof P; Anetta U
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):671-677. PubMed ID: 33284572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.
    Potpara TS; Ferro CJ; Lip GYH
    Nat Rev Nephrol; 2018 May; 14(5):337-351. PubMed ID: 29578207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
    Washam JB; Holmes DN; Thomas LE; Pokorney SD; Hylek EM; Fonarow GC; Mahaffey KW; Gersh BJ; Kowey PR; Ansell JE; Go AS; Reiffel JA; Freeman JV; Singer DE; Naccarelli G; Blanco R; Peterson ED; Piccini JP
    J Am Heart Assoc; 2018 Sep; 7(18):e008928. PubMed ID: 30371218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
    Miller CS; Grandi SM; Shimony A; Filion KB; Eisenberg MJ
    Am J Cardiol; 2012 Aug; 110(3):453-60. PubMed ID: 22537354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.
    Janzic A; Kos M
    Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation.
    Harrington AR; Armstrong EP; Nolan PE; Malone DC
    Stroke; 2013 Jun; 44(6):1676-81. PubMed ID: 23549134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Choice of Anticoagulant Therapy in Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease].
    Koziolova NA; Polyanskaya EA; Kolegova II
    Kardiologiia; 2017 Jan; (1):76-85. PubMed ID: 28290837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation.
    Ng KP; Edwards NC; Lip GY; Townend JN; Ferro CJ
    Am J Kidney Dis; 2013 Sep; 62(3):615-32. PubMed ID: 23746378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.